1. Introduction

The Right Not to Know Genetic Risk Predictions is an important principle in biotechnology law, medical ethics, genetic privacy, bioethics and human-rights jurisprudence.

It refers to an individual's right to refuse information about genetic characteristics, inherited diseases, future health risks, hereditary predispositions or possible biological conditions that may be discovered through genetic testing.

For example, a genetic test may reveal that an individual has:

A high genetic predisposition to Alzheimer's disease.

An inherited risk of breast or ovarian cancer.

A genetic susceptibility to cardiovascular diseases.

A hereditary mutation associated with Huntington's disease.

A genetic predisposition to certain psychiatric or neurological conditions.

Even where such information is medically relevant, an individual may not wish to receive it.

The fundamental legal question is:

Should a person be legally compelled to know information about their genetic future, or should they have the freedom to remain unaware?

The right not to know protects personal autonomy, psychological integrity, informational privacy, dignity and freedom of medical decision-making.

It is closely connected with the right to privacy and the right to informed consent.

Importantly, the right is not simply a right to refuse medical treatment. It also concerns the refusal to receive particular medical information.

2. Meaning and Scope of the Right

The right not to know genetic risk predictions means that a person can choose not to receive certain genetic findings, including predictive and incidental findings.

It generally covers five important categories.

A. Predictive genetic information

Information indicating that a person may develop a disease in the future.

For example, a genetic test identifies a mutation associated with Huntington's disease.

B. Susceptibility information

Information suggesting an increased probability of developing a disease without establishing that the disease will actually occur.

C. Incidental genetic findings

Unexpected discoveries made during genetic testing conducted for another medical purpose.

For example, a test intended to identify one hereditary disorder unexpectedly reveals a mutation associated with another serious disease.

D. Reproductive genetic information

Information concerning inherited disorders that may affect future children or reproductive decisions.

E. Familial genetic information

Information that may reveal hereditary risks affecting biological relatives.

The right creates a legal and ethical distinction between the right to receive medical information and the right to refuse it.

3. International Legal Framework

A. Universal Declaration on Bioethics and Human Rights, 2005

Article 5 recognises individual autonomy and responsibility in making decisions.

Article 6 establishes the importance of free and informed consent.

Article 9 protects privacy and confidentiality.

These provisions support the argument that individuals should exercise control over whether they receive predictive genetic information.

B. Convention on Human Rights and Biomedicine (Oviedo Convention), 1997

One of the most important international instruments is the Oviedo Convention.

Article 10(2) expressly provides that everyone's wishes to be informed or not to be informed about their health information must be respected.

Article 10(3) recognises exceptional legal restrictions on these rights in the interests of the individual.

This is particularly important because it explicitly recognises the right not to know, rather than merely deriving it from general privacy principles.

No. 203

C. European Convention on Human Rights

Article 8 protects the right to respect for private and family life.

Genetic information falls within the sphere of private life because it reveals deeply personal biological and familial information.

The right to refuse genetic information can therefore be supported by Article 8, particularly where compulsory disclosure interferes with personal autonomy.

D. GDPR, 2016

The General Data Protection Regulation provides substantial protection for genetic data.

Relevant provisions include:

Article 4(13): Defines genetic data.

Article 9: Provides special protection for genetic and other sensitive personal data.

Article 5: Establishes data-processing principles, including transparency, purpose limitation and data minimisation.

Article 7: Establishes conditions for valid consent.

Article 15: Provides access rights concerning personal data.

The GDPR does not expressly establish a universal, unconditional right to refuse knowledge of genetic predictions. However, its privacy and data-protection framework supports individual control over genetic information.

4. Important Judicial Decisions and Case Laws

There is an important distinction between judgments that directly recognise a right not to know genetic information and judgments that establish broader principles of privacy, consent and bodily autonomy. Several leading cases provide the legal foundation for this right.

Case 1: S. and Marper v. United Kingdom (2008)

European Court of Human Rights

Citation: Applications Nos. 30562/04 and 30566/04, Judgment of 4 December 2008.

Facts:

The applicants challenged the indefinite retention of their fingerprints, cellular samples and DNA profiles by British authorities after criminal proceedings had ended without conviction.

Legal issues:

Whether retaining DNA information violated private life.

Whether genetic material deserved special privacy protection.

Whether the State could retain sensitive biological information without sufficient justification.

Judgment:

The European Court of Human Rights found a violation of Article 8 of the European Convention on Human Rights.

The Court emphasised that cellular samples contain extensive personal information, including health-related information and genetic characteristics relevant to an individual's relatives.

Relevance to the right not to know:

Although the case did not directly decide the right to refuse genetic risk predictions, it established that genetic information is exceptionally sensitive and deserves strong protection against unjustified interference.

Bailii

Case 2: National Federation of Independent Business v. Sebelius – Not applicable; the leading US genetic privacy framework is GINA

A more directly relevant legal framework is the Genetic Information Nondiscrimination Act 2008 (GINA), United States.

GINA prohibits specified forms of genetic discrimination in health insurance and employment.

Its significance is that individuals should not be disadvantaged because of genetic information indicating future disease susceptibility.

For example, an employer generally cannot use an employee's genetic information to make employment decisions.

Legal significance:

GINA does not establish a comprehensive right not to know genetic information. Nevertheless, it protects people against certain consequences of genetic predictions and reduces the pressure to undergo or disclose genetic testing.

Case 3: Justice K.S. Puttaswamy v. Union of India (2017)

Supreme Court of India

Citation: (2017) 10 SCC 1.

Facts:

The case concerned whether privacy was constitutionally protected as a fundamental right under the Indian Constitution.

Legal issues:

Whether privacy is protected by Article 21.

Whether informational privacy forms part of constitutional privacy.

Whether individuals have autonomy over personal information.

Judgment:

The nine-judge Constitution Bench unanimously recognised privacy as a fundamental right.

The judgment discussed several dimensions of privacy, including:

Bodily privacy.

Informational privacy.

Decisional autonomy.

Personal dignity.

Individual control over intimate personal information.

Relevance to genetic risk predictions:

Genetic information reveals intimate details about an individual's biological characteristics, possible future illnesses and family relationships.

The principles in Puttaswamy provide a strong constitutional basis for arguing that an individual should have control over receiving, withholding and disclosing predictive genetic information.

In India, however, the judgment did not expressly establish a separate, fully developed right not to know genetic predictions.

Case 4: Selvi v. State of Karnataka (2010)

Supreme Court of India

Citation: (2010) 7 SCC 263.

Facts:

The case concerned the involuntary administration of narcoanalysis, polygraph examinations and brain electrical activation profile tests.

Legal issues:

Whether involuntary investigative techniques violated personal liberty.

Whether bodily autonomy was protected under Article 21.

Whether compulsory extraction of personal information violated Article 20(3).

Judgment:

The Supreme Court held that involuntary administration of these techniques violated constitutional protections.

The Court recognised the importance of personal autonomy and the right against compelled self-incrimination in the relevant context.

Relevance to genetic information:

The judgment supports the broader proposition that the State cannot freely compel individuals to undergo intrusive procedures for extracting personal information.

Its principles may be relevant to compulsory genetic testing, although the case itself did not concern predictive genetic testing or the right not to receive test results.

Case 5: Montgomery v. Lanarkshire Health Board (2015)

United Kingdom Supreme Court

Citation: [2015] UKSC 11.

Facts:

A pregnant woman with diabetes was not adequately informed about the material risks associated with vaginal delivery and the alternative of caesarean delivery.

Legal issue:

Whether medical professionals must disclose material risks so that patients can make informed decisions.

Judgment:

The UK Supreme Court held that doctors must take reasonable care to ensure that patients are aware of material risks and reasonable alternative treatments.

Relevance:

The case reinforces patient autonomy and informed decision-making.

Applied to genetic testing, the principle supports providing appropriate pre-test counselling about the possibility of discovering unwanted predictive information.

However, the duty to inform does not mean that every patient must be forced to receive every genetic finding. The patient's preferences concerning information should be considered.

Case 6: Pretty v. United Kingdom (2002)

European Court of Human Rights

Citation: Application No. 2346/02, Judgment of 29 April 2002.

Facts:

The applicant, who suffered from motor neurone disease, challenged the legal restrictions affecting assistance in ending her life.

Legal issues:

The Court considered dignity, personal autonomy, private life and Article 8 of the European Convention on Human Rights.

Judgment:

The Court recognised that personal autonomy is an important principle underlying Article 8, although it did not find that the Convention guaranteed the particular right claimed by the applicant.

Relevance:

The autonomy principles are relevant to genetic information because individuals may have legitimate reasons for refusing knowledge about future medical conditions.

The case is supportive by analogy, not a direct genetic-information precedent.

Case 7: Aucrinde, Case C-196/24 (2026)

Court of Justice of the European Union

Citation: Case C-196/24, ECLI:EU:C:2026:587, judgment of 16 July 2026.

Subject: Post-mortem genetic testing, human dignity, genetic origins and fundamental rights.

The case concerned cross-border judicial cooperation involving the proposed exhumation of a deceased person for genetic testing to establish parentage.

The Court considered the relationship between human dignity, private life and the interests of individuals seeking to establish their genetic origins.

Relevance:

Although this case concerns the right to know genetic origins rather than the right not to know predictive disease risks, it is significant for the broader principle that genetic testing raises fundamental questions of human dignity, privacy and individual interests.

It demonstrates that genetic testing cannot be treated as an ordinary evidentiary procedure without considering fundamental rights.

Documents+1

5. Right Not to Know Under Indian Law

India does not currently have a specific, comprehensive statute expressly establishing a standalone right not to know genetic risk predictions.

Nevertheless, several constitutional and statutory principles can support such a right.

A. Article 21 – Right to Life and Personal Liberty

Article 21 protects life and personal liberty.

The constitutional interpretation developed in Puttaswamy supports:

Personal autonomy.

Medical decision-making.

Informational privacy.

Human dignity.

Protection against unjustified intrusion into personal life.

Consequently, compulsory disclosure of genetic predictions may raise constitutional concerns.

B. Article 14 – Right to Equality

Genetic information may create discrimination based on hereditary characteristics.

For example, a person with a genetic predisposition to cancer might face unfair treatment in employment or access to services.

Article 14 may become relevant where State action creates arbitrary distinctions based on genetic characteristics.

C. Digital Personal Data Protection Act, 2023

The DPDP Act provides a general framework for processing digital personal data.

Genetic information that identifies an individual or can be linked to an identifiable individual may fall within its scope.

Its provisions concerning lawful processing, consent, data security and individual rights may become relevant to genetic databases and predictive testing services.

However, the Act does not expressly create a distinct right not to receive genetic predictions.

D. Information Technology Act, 2000 and SPDI Rules, 2011

The Information Technology (Reasonable Security Practices and Procedures and Sensitive Personal Data or Information) Rules, 2011 include medical records, medical history and physical or physiological information within specified sensitive-information categories.

These provisions may be relevant to the collection and disclosure of genetic health information, depending on the information and processing involved.

6. Legal Duties of Doctors and Genetic Counsellors

Healthcare professionals have an important responsibility to respect the patient's preferences concerning genetic information.

Their responsibilities include:

1. Pre-test counselling

Patients should be informed about the nature of the genetic test and the possibility of discovering unexpected findings.

2. Respecting refusal

Where a patient declines predictive information, healthcare professionals should ordinarily respect that decision, subject to applicable law and exceptional circumstances.

3. Incidental findings

Doctors should establish in advance how unexpected findings will be handled.

4. Confidentiality

Genetic information must be protected against unauthorised disclosure.

5. Avoiding psychological harm

Healthcare professionals should consider the psychological consequences of disclosing information about incurable or currently untreatable genetic conditions.

6. Respecting informed consent

Consent to undergo a genetic test should not automatically be treated as consent to receive every possible result.

This distinction is particularly important in whole-genome sequencing, where one test can reveal numerous unrelated genetic risks.

7. Exceptions and Limitations to the Right Not to Know

The right not to know is important, but it is not necessarily absolute.

Certain circumstances may create competing legal and ethical interests.

A. Serious risk to biological relatives

A genetic result may reveal that close relatives face a serious hereditary health risk.

For example, a person may carry a pathogenic BRCA1 mutation that could have implications for biological relatives.

The legal question is whether healthcare professionals can disclose information to relatives without the patient's permission.

The usual starting point is confidentiality. Any exception requires careful consideration of applicable law, the seriousness and preventability of harm, and whether disclosure can be justified.

B. Preventable medical conditions

Where a genetic finding identifies a serious condition that can be prevented or effectively treated, healthcare professionals may have stronger reasons to discuss the information with the patient.

Nevertheless, medical benefit alone does not automatically eliminate the patient's right to refuse knowledge.

C. Public-health emergencies

In exceptional circumstances, legislation may permit limited disclosure or processing of genetic information for legitimate public-health purposes.

Such action must have an appropriate legal basis and satisfy applicable safeguards.

D. Children's genetic testing

The position is particularly complicated when predictive genetic testing concerns children.

Testing for an immediately treatable childhood condition may be justified by the child's best interests.

However, testing a child for an adult-onset disease with no available childhood intervention may unnecessarily eliminate that individual's future choice about whether to know.

E. Court-ordered genetic testing

Courts may authorise genetic testing in particular legal proceedings, such as parentage disputes.

However, the need for genetic evidence must be balanced against privacy, dignity, consent and applicable statutory requirements.

8. Major Legal and Ethical Conflicts

9. Emerging Challenges in Biotechnology Law

Modern biotechnology creates additional challenges for the right not to know.

1. Artificial intelligence-based genetic prediction

AI systems can analyse genomic information and estimate future disease susceptibility. Individuals may receive predictions they never specifically requested.

2. Whole-genome sequencing

A single sequencing procedure can reveal information about numerous diseases, hereditary conditions and biological relationships.

3. Direct-to-consumer genetic testing

Commercial testing companies may provide genetic risk reports without adequate counselling or explanation of predictive uncertainty.

4. Genetic databases

Genetic information may be retained and analysed for purposes beyond the original medical test.

5. Cross-border genetic data transfers

Genetic information may be transferred between countries with different standards of privacy and medical confidentiality.

6. Predictive algorithms

An algorithm may classify someone as genetically high-risk even when the scientific evidence is uncertain.

This raises questions about accuracy, explainability, discrimination and the right to refuse predictive classifications.

10. Recommendations for Legal and Regulatory Reform

A comprehensive legal framework should introduce the following safeguards:

Express recognition of the right not to receive predictive genetic information.

Mandatory pre-test counselling for complex predictive genetic testing.

Separate consent for incidental findings.

Clear procedures for recording a patient's refusal to receive results.

Protection against unauthorised disclosure to employers and insurers.

Special safeguards for genetic testing involving children.

Strict confidentiality requirements for genetic databases.

Independent oversight of AI-based genetic prediction systems.

Clear rules governing disclosure to biological relatives.

Effective remedies for violations of genetic privacy and autonomy.

11. Critical Legal Analysis

The right not to know genetic risk predictions creates a difficult balance between individual autonomy and medical responsibility.

On one side, access to genetic information may enable early diagnosis, preventive treatment and informed reproductive decisions.

On the other side, receiving unwanted information may produce anxiety, discrimination, family conflict and psychological distress.

Furthermore, genetic predictions are not always definitive. A genetic predisposition does not necessarily mean that an individual will develop the relevant disease.

Therefore, the law should distinguish between:

A confirmed genetic diagnosis.

A pathogenic genetic mutation.

A probabilistic disease prediction.

A scientifically uncertain genetic association.

An incidental genetic discovery.

A person should not be treated as medically ill merely because an algorithm predicts an increased genetic risk.

The legal framework should preserve the individual's ability to decide whether predictive information is received, subject to carefully defined legal exceptions.

12. Conclusion

The Right Not to Know Genetic Risk Predictions is an essential dimension of informational privacy, bodily autonomy, human dignity and medical self-determination.

The Oviedo Convention provides particularly important express recognition through Article 10(2). Judicial decisions such as Puttaswamy, S. and Marper, Selvi and Montgomery provide supporting principles concerning privacy, consent and autonomy.

However, these decisions should not be misrepresented as establishing an identical, universally enforceable right not to know genetic predictions.

For India, constitutional privacy jurisprudence provides a substantial foundation for developing this protection, although more specific legislation and judicial clarification would strengthen it.

Ultimately, genetic technology should empower individuals to make informed choices about their biological future, not deprive them of the freedom to remain unaware of information they do not wish to receive.

13. Important Legal Authorities – Quick Reference

Research note: The distinction between directly applicable law and supporting case-law analogies is important when using this topic in a dissertation, research paper or legal examination.